The Leadership Team at NodThera collaboratively drives the company's strategic vision and operational efficiency, overseeing the discovery and development of innovative biotechnology treatments. This team, composed of experts in various scientific and business disciplines, ensures alignment between research initiatives and market strategy, facilitating the advancement of therapies that target unmet medical needs.
Alan Watt
President & CSO
Alison Strutt
Chief Operating Officer
David Harrison FRSC
Vp, Medicinal Chemistry
Karolina Chwałek
Vice President Of Business Dev...
Mark Bock
VP of Chemistry
Nick Clarke
Chief Development Officer
Nicola Lindsay
VP Of Preclinical Development
Valérie Reader
Vice President of Scientific O...
View all